Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)
| The Manila Times
New PATHOMIQ AI integration helps clinicians tailor active surveillance with greater confidence